Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy (2015)
- Authors:
- Severino, Patrícia - Universidade Estadual de Campinas (UNICAMP)
- Szymanski, Marcelo - Universidade Estadual de Campinas (UNICAMP)
- Favaro, Marianna Teixeira de Pinho - Universidade Estadual de Campinas (UNICAMP)
- Azzoni, Adriano Rodrigues
- Chaud, Marco Vinicius - Universidade de Sorocaba (UNISO)
- Santana, Maria Helena A - Universidade Estadual de Campinas (UNICAMP)
- Silva, Amélia M
- Souto, Eliana B
- Severino, Patrícia - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: AZZONI, ADRIANO RODRIGUES - EP
- Unidade: EP
- DOI: 10.1016/j.ejps.2014.09.021
- Subjects: LIPÍDEOS; NANOPARTÍCULAS; PROTEÍNAS; NANOTECNOLOGIA; GENES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Journal of Pharmaceutical Sciences
- ISSN: 1879-0720
- Volume/Número/Paginação/Ano: v. 66, p. 78-82, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SEVERINO, Patrícia et al. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, v. 66, p. 78-82, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2014.09.021. Acesso em: 02 jul. 2024. -
APA
Severino, P., Szymanski, M., Favaro, M. T. de P., Azzoni, A. R., Chaud, M. V., Santana, M. H. A., et al. (2015). Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, 66, 78-82. doi:10.1016/j.ejps.2014.09.021 -
NLM
Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021 -
Vancouver
Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021 - A novel protein refolding protocol for the solubilization and purification of recombinant peptidoglycan-associated lipoprotein from Xylella fastidiosa overexpressed in Escherichia coli
- Characterization of an oxidative stress response regulator, homologous to Escherichia coli OxyR, from the phytopathogen Xylella fastidiosa
- Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery
- Physicochemical and in vitro evaluation of cationic liposome, hyaluronic acid and plasmid DNA as pseudo-ternary complexes for gene delivery
- Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy
- Scalable production of highly concentrated chitosan/TPP nanoparticles in different pHs and evaluation of the in vitro transfection efficiency
- Impact of plasmid quality on lipoplex-mediated transfection
- Evaluation of siRNA and cationic liposomes complexes as a model for in vitro siRNA delivery to cancer cells
- Development of a non-viral gene delivery vector based on the dynein light chain Rp3 and the TAT peptide
- Recombinant protein-based nanocarriers and their association with cationic liposomes: characterization and in vitro evaluation
Informações sobre o DOI: 10.1016/j.ejps.2014.09.021 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas